| Primary |
| Product Used For Unknown Indication |
28.8% |
| Drug Use For Unknown Indication |
23.7% |
| Bone Sarcoma |
5.1% |
| Desmoplastic Small Round Cell Tumour |
3.4% |
| Metastatic Uterine Cancer |
3.4% |
| Prophylaxis |
3.4% |
| Sarcoma |
3.4% |
| Systemic Lupus Erythematosus |
3.4% |
| Acute Biphenotypic Leukaemia |
2.8% |
| Chemotherapy |
2.8% |
| Non-hodgkin's Lymphoma |
2.8% |
| Prophylaxis Of Nausea And Vomiting |
2.8% |
| Breast Cancer |
2.3% |
| Ovarian Cancer |
2.3% |
| Small Cell Lung Cancer Stage Unspecified |
2.3% |
| Vomiting |
2.3% |
| Burkitt's Lymphoma |
1.7% |
| Analgesic Therapy |
1.1% |
| Computerised Tomogram |
1.1% |
| Endometrial Sarcoma |
1.1% |
|
| Febrile Neutropenia |
14.7% |
| Renal Failure |
14.7% |
| Anaphylactic Reaction |
8.8% |
| Encephalopathy |
8.8% |
| Myelodysplastic Syndrome |
8.8% |
| Toxic Encephalopathy |
8.8% |
| Cystitis Haemorrhagic |
5.9% |
| Nausea |
5.9% |
| Chest Pain |
2.9% |
| Face Oedema |
2.9% |
| Hyperthermia |
2.9% |
| Oropharyngeal Pain |
2.9% |
| Pancytopenia |
2.9% |
| Renal Tubular Atrophy |
2.9% |
| Thrombocytopenia |
2.9% |
| Vomiting |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
23.4% |
| Drug Use For Unknown Indication |
22.4% |
| Hodgkin's Disease |
10.3% |
| Bone Sarcoma |
8.1% |
| Diffuse Large B-cell Lymphoma |
3.9% |
| Lymphoma |
3.9% |
| Non-hodgkin's Lymphoma |
3.8% |
| Breast Cancer |
3.2% |
| Sarcoma |
3.0% |
| Testis Cancer |
2.8% |
| Vasculitis Cerebral |
2.2% |
| B-cell Lymphoma Stage Iv |
1.9% |
| Central Nervous System Lymphoma |
1.6% |
| Leiomyosarcoma |
1.6% |
| Microscopic Polyangiitis |
1.6% |
| Prophylaxis |
1.5% |
| Premedication |
1.4% |
| Hodgkin's Disease Stage Iv |
1.2% |
| Fluid Replacement |
1.1% |
| Liposarcoma |
1.1% |
|
| Vomiting |
24.7% |
| Fatigue |
9.9% |
| Renal Failure |
8.6% |
| Glomerular Filtration Rate Decreased |
7.4% |
| Cytolytic Hepatitis |
6.2% |
| Encephalopathy |
3.7% |
| Erythema |
3.7% |
| Pyrexia |
3.7% |
| Renal Tubular Disorder |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| Angioedema |
2.5% |
| Atrial Flutter |
2.5% |
| Bone Marrow Failure |
2.5% |
| Cerebral Infarction |
2.5% |
| Confusional State |
2.5% |
| Hypotension |
2.5% |
| Interstitial Lung Disease |
2.5% |
| Mucosal Inflammation |
2.5% |
| Neurotoxicity |
2.5% |
| Neutropenia |
2.5% |
|
| Concomitant |
| Rhabdomyosarcoma |
25.8% |
| Chemotherapy |
22.6% |
| Drug Use For Unknown Indication |
19.4% |
| Diffuse Large B-cell Lymphoma Stage Ii |
12.9% |
| Pyrexia |
12.9% |
| Nausea |
6.5% |
|
| Urine Output Decreased |
66.7% |
| Paraesthesia |
33.3% |
|
